Celldex Therapeutics Presents Positive Data from
- Data updates at EAACI 2023 continue to position barzolvolimab as a potential best-in-class addition to a historically limited treatment landscape -- At...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Eva Grekowitz. Real-time updates on events, politics, business and more.